John R Moore is General Counsel of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 6,531 shares of EWTX, which is worth approximately $82,355. The most recent transaction as insider was on Jun 03, 2022, when has been sold 15,230 shares (Common Stock) at a price of $1.93 per share, resulting in proceeds of $29,394. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.53K
100.83% 3M change
100.83% 12M change
Total Value Held $82,355

JOHN R MOORE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2022
BUY
Exercise of conversion of derivative security
$29,394 $1.93 p/Share
15,230 Added 45.52%
18,230 Common Stock
May 16 2022
SELL
Open market or private sale
$80,136 $7.42 p/Share
10,800 Reduced 78.26%
3,000 Common Stock
Jan 21 2022
BUY
Exercise of conversion of derivative security
$3,834 $0.71 p/Share
5,400 Added 30.4%
12,362 Common Stock
Dec 28 2021
BUY
Exercise of conversion of derivative security
$3,834 $0.71 p/Share
5,400 Added 43.68%
6,962 Common Stock
JRM

John R Moore

General Counsel
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX